Business Description
China Reform Health Management And Services Group Co Ltd
ISIN : CNE000000255
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.14 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | -3 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 10.62 | |||||
Beneish M-Score | -2.32 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 16.2 | |||||
3-Year EBITDA Growth Rate | 43.1 | |||||
3-Year EPS without NRI Growth Rate | 22.1 | |||||
3-Year FCF Growth Rate | -11.2 | |||||
3-Year Book Growth Rate | 10.5 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.73 | |||||
9-Day RSI | 45.47 | |||||
14-Day RSI | 44.18 | |||||
6-1 Month Momentum % | -18.96 | |||||
12-1 Month Momentum % | -21.12 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.99 | |||||
Quick Ratio | 2.98 | |||||
Cash Ratio | 2.51 | |||||
Days Inventory | 4.43 | |||||
Days Sales Outstanding | 151.54 | |||||
Days Payable | 17.55 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.1 | |||||
Shareholder Yield % | -1.39 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 23.41 | |||||
Operating Margin % | -32.53 | |||||
Net Margin % | -23.68 | |||||
FCF Margin % | -54.06 | |||||
ROE % | -8.11 | |||||
ROA % | -5.44 | |||||
ROIC % | -19.32 | |||||
ROC (Joel Greenblatt) % | -474.89 | |||||
ROCE % | -7.35 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 25.2 | |||||
PB Ratio | 6.22 | |||||
Price-to-Tangible-Book | 7.09 | |||||
EV-to-EBIT | -111.53 | |||||
EV-to-EBITDA | -111.53 | |||||
EV-to-Revenue | 24.03 | |||||
EV-to-FCF | -44.46 | |||||
Price-to-Median-PS-Value | 0.23 | |||||
Price-to-Net-Current-Asset-Value | 8.4 | |||||
Price-to-Net-Cash | 11.09 | |||||
Earnings Yield (Greenblatt) % | -0.9 | |||||
FCF Yield % | -2.03 | |||||
Forward Rate of Return (Yacktman) % | -16.08 |